Publish date:

Wednesday's ETF Winners & Losers

Funds tacking chipmakers are among Wednesday's worst performers.
Author:

Exchange-traded funds tracking semiconductors were among the worst performers Wednesday, after a bearish analyst report on expected chip prices and

Micron Technology's

(MU) - Get Report

disappointing quarter.

Micron was sliding nearly 9% after swinging to a fiscal fourth-quarter loss, while Merrill Lynch initiated coverage of

Intel

(INTC) - Get Report

,

Advanced Micro Devices

(AMD) - Get Report

and

Nvidia

(NVDA) - Get Report

with underweight ratings.

The

Ultra Semiconductor ProShares

(USD) - Get Report

was shedding $3.71, or 4.1%, to $87.58. The

Semiconductor HOLDRs

(SMH) - Get Report

was losing 89 cents, or 2.23, to $38.07. The

iShares S&P GSTI Semiconductor

(IGW)

was off $1.49, or 2.2%, to $67.53.

Funds tracking Chinese markets also were among the losers. Hong Kong's Hang Seng index lost 719.81 points overnight.

The

iShares FTSE/Xinhua China 25 Index

(FXI) - Get Report

was losing $11.09, or 5.9%, to $178.40. The

SPDR S&P China

(GXC) - Get Report

was shedding $5.67, or 5.8%, to $92.94. The

PowerShares Golden Dragon Halter USX China

(PGJ) - Get Report

was off $1.61, or 4.6%, to $33.21.

Funds tracking homebuilders were among the session's few winners, as several holdings continued their run-up a second day.

TST Recommends

Beazer Homes

(BZH) - Get Report

,

Standard Pacific

(SPF)

and

Brookfield Homes

(BHS)

were all up more than 3.5%.

The

iShares Dow Jones US Home Construction

(ITB) - Get Report

was gaining 60 cents, or 2.7%, to $22.46. The

iShares FTSE NAREIT Residential

(REZ) - Get Report

was adding 79 cents, or 1.7%, to $48.70.

Biotech- and pharmaceutical-related funds also were among the winners.

Arena Pharmaceuticals

(ARNA) - Get Report

,

Imclone Systems

(IMCL)

and

Genzyme

(GENZ)

were all adding more than 3%.

The

SPDR S&P Biotech

(XBI) - Get Report

was gaining $1.01, or 1.7%, to $59.56. The

Ultra Health Care ProShares

(RXL) - Get Report

was tacking on 75 cents, or 1%, to $74.70. The

Pharmaceutical HOLDRs

(PPH) - Get Report

was adding 74 cents, or 0.9%, to $81.82.